Found 21 matching trials
Asacol Acute Diverticulitis(DIVA)Study
PHASE2The purpose of this study is to determine whether AsacolĀ® 2.4 g/day (400 mg...
Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
PHASE3The purpose of this study is to determine whether low dose AsacolĀ® (27 mg/k...
Cimzia Versus Mesalamine for Crohn's Recurrence
PHASE4Hypothesis: Cimzia provides superior reduction in endoscopic and clinical r...
Location
Penn State Milton S. Hershey Medical Center
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
PHASE3To demonstrate that import Mesalazine (ASACOLĀ®) is non-inferior to the refe...
Location
Shanghai Hospital
Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy
PHASE3RA (Rheuatoid arthritis) is a multisystem disease that mainly involves join...
Location
Department of Clinical Immunology , Jawaharlal Institute of Post graduate Medical Educationa and Research
Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis
PHASE2The exact underlying mechanisms of ulcerative colitis (UC), an idiopathic, ...
Location
Faculty of Medicine, Mansoura University
Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
PHASE1This study evaluated pharmacokinetics of 5-ASA and N-Ac-5-ASA associated wi...
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
PHASE2The purpose of this study is to evaluate the safety and efficacy of HMPL-00...
Location
Multiple Locations
Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
PHASE2Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease char...
Location
Faculty of Medicine, Mansoura University
Assessing the Safety/Efficacy of AsacolĀ® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
PHASE3The overall objective of this study is to assess the safety and efficacy of...
Location
Research Facility